Form D · Biotechnology
Otomagnetics, Inc.
Rockville, MD · CIK 0001711666
Offering snapshot reported Mar 27, 2018 · SEC filing
- Reported sold
- $1.03M Offering amount: $3.41M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 19, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 27, 2018 | Initial | $1,029,014 | No comparison | 2 | SEC filing |
| Jul 12, 2017 | Initial | $260,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-308673
Includes cash proceeds and proceeds of indebtedness in the amount of $405,000 (consisting of principal and accrued interest) that is expected to be converted as part of this offering, which indebtedness was previously issued and disclosed.
Source: Form D, filed Mar 27, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Abhita Batra | Director, Executive |
| David Beylin | Director |
| Neela Chipalkatty | Director |
| Ting Pau Oei | Director, Executive |
| Benjamin Shapiro | Director, Executive |
| Irving Weinberg | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12156 B Parklawn Drive
Rockville, MD, 20852
Rockville, MD, 20852